Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 1, 1984
Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine
E Cecchin, S De Marchi, G Panarello, et al.
Nephron
|
January 1, 1983
More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis
S De Marchi, E Cecchin, A Basile, et al.
The International Journal of Artificial Organs
|
March 1, 1983
Origin of glycosylated hemoglobin A1 in chronic renal failure
S De Marchi, E Cecchin, C Camurri, et al.
Contributions to Nephrology
|
January 1, 1990
Autoimmune markers in hereditary nephritis
E Cecchin, S De Marchi, G Panarello, et al.
Clinical Pharmacology and Therapeutics
|
January 12, 2017
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype
R Roncato, E Cecchin, M Montico, et al.
Frontiers in Pharmacology
|
May 31, 2023
Ten-year experience with pharmacogenetic testing for <i>DPYD</i> in a national cancer center in Italy: Lessons learned on the path to implementation
A Bignucolo, E De Mattia, R Roncato, et al.
Clinical and Experimental Immunology
|
May 1, 1984
Immunological characterization of renal glycosuria patients
P De Paoli, S Battistin, A Jus, et al.
International Journal of Immunogenetics
|
January 12, 2016
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight
M Garziera, E Catamo, S Crovella, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 19, 2010
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
Valli De Re, R Cannizzaro, V Canzonieri, et al.
The Pharmacogenomics Journal
|
August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
E Cecchin, M D'Andrea, S Lonardi, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 1, 1984
Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine
E Cecchin, S De Marchi, G Panarello, et al.
Nephron
|
January 1, 1983
More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis
S De Marchi, E Cecchin, A Basile, et al.
The International Journal of Artificial Organs
|
March 1, 1983
Origin of glycosylated hemoglobin A1 in chronic renal failure
S De Marchi, E Cecchin, C Camurri, et al.
Contributions to Nephrology
|
January 1, 1990
Autoimmune markers in hereditary nephritis
E Cecchin, S De Marchi, G Panarello, et al.
Clinical Pharmacology and Therapeutics
|
January 12, 2017
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype
R Roncato, E Cecchin, M Montico, et al.
Frontiers in Pharmacology
|
May 31, 2023
Ten-year experience with pharmacogenetic testing for <i>DPYD</i> in a national cancer center in Italy: Lessons learned on the path to implementation
A Bignucolo, E De Mattia, R Roncato, et al.
Clinical and Experimental Immunology
|
May 1, 1984
Immunological characterization of renal glycosuria patients
P De Paoli, S Battistin, A Jus, et al.
International Journal of Immunogenetics
|
January 12, 2016
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight
M Garziera, E Catamo, S Crovella, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 19, 2010
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
Valli De Re, R Cannizzaro, V Canzonieri, et al.
The Pharmacogenomics Journal
|
August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
E Cecchin, M D'Andrea, S Lonardi, et al.
Page
of 9